Background Non-alcoholic fatty liver disease is a major health problem worldwide.
Resveratrol is a natural polyphenol found in edible plants that has a variety of biochemical …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

Background: Recent studies demonstrated that resveratrol has many therapeutic effects on
liver disorders. Resveratrol significantly increased survival after liver transplantation …

Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …

Many studies have shown that resveratrol has a lot of therapeutic effects on liver disorders.
Its administration can significantly increase the survival rate after liver transplantation …

Non-alcoholic fatty liver disease (NAFLD) is usually associated with insulin resistance,
central obesity, reduced glucose tolerance, type 2 diabetes mellitus and …

Non-alcoholic fatty liver disease (NAFLD) is regarded as one of the most common liver
pathologies in many societies. Resveratrol, as a phenolic compound with powerful …

Background There are current trials investigating the effect of resveratrol supplementation
on lipid profiles and liver enzymes among patients with metabolic syndrome (MetS) and …

Background & Aims Nonalcoholic fatty liver disease (NAFLD), characterized by
accumulation of hepatic triglycerides (steatosis), is associated with abdominal obesity …

We performed the largest randomized, placebo‐controlled clinical trial to date (N= 112, 12‐
week intervention) to investigate the effects and safety of resveratrol supplementation on …